Cargando…

The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation

Metastasis and chemoresistance are major causes of poor prognosis in patients with esophageal squamous cell carcinoma (ESCC), manipulated by multiple factors including deubiquitinating enzyme (DUB). DUB PSMD14 is reported to be a promising therapeutic target in various cancers. Here, we explored the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jing, Chao, Li, Xingchen, Zhou, Mengqian, Zhang, Shengchi, Lai, Qingchuan, Liu, Dandan, Ye, Beibei, Li, Linqi, Wu, Yue, Li, Hong, Yue, Kai, Chen, Peng, Yao, Xiaofeng, Wu, Yansheng, Duan, Yuansheng, Wang, Xudong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058732/ https://www.ncbi.nlm.nih.gov/pubmed/33897885 http://dx.doi.org/10.7150/thno.46109

Ejemplares similares

Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness
por: Jing, Chao, et al.
Publicado: (2021)

JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4
por: Jing, Chao, et al.
Publicado: (2021)

Clinical characteristics and outcomes of cervical lymph node metastasis from unknown primary sites: a single institution’s 14-year experience
por: Zhou, Mengqian, et al.
Publicado: (2023)

Detection of thyroglobulin in fine-needle aspiration for diagnosis of metastatic lateral cervical lymph nodes in papillary thyroid carcinoma: A retrospective study
por: Wang, Yuxuan, et al.
Publicado: (2022)

Diagnostic Model Incorporating Clinicopathological Characteristics of Delphian Lymph Node Metastasis Risk Profiles in Papillary Thyroid Cancer
por: Li, Xingchen, et al.
Publicado: (2021)

Evidence on the therapeutic role of thiolutin in imiquimod‐induced psoriasis‐like skin inflammation in mice
por: Wang, Aixue, et al.
Publicado: (2023)

LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2
por: Duan, Yuansheng, et al.
Publicado: (2023)

Correction: LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2
por: Duan, Yuansheng, et al.
Publicado: (2023)

Pattern and Predictive Factors of Metastasis in Lymph Nodes Posterior to the Right Recurrent Laryngeal Nerve in Papillary Thyroid Carcinoma
por: Zhou, Mengqian, et al.
Publicado: (2022)

Depletion of PSMD14 suppresses bladder cancer proliferation by regulating GPX4
por: Jia, Changxin, et al.
Publicado: (2023)

Surgical Extent of Central Lymph Node Dissection for Papillary Thyroid Carcinoma Located in the Isthmus: A Propensity Scoring Matched Study
por: Shuai, Yanjie, et al.
Publicado: (2021)

Development and Validation of a Nomogram based on cell growth-related Biomarkers for Oral Squamous Cell Carcinoma
por: Shuai, Yanjie, et al.
Publicado: (2021)

Targeting PSMD14 inhibits melanoma growth through SMAD3 stabilization
por: Yokoyama, Satoru, et al.
Publicado: (2020)

PSMD2 contributes to the progression of esophageal squamous cell carcinoma by repressing autophagy
por: Liu, Yachen, et al.
Publicado: (2023)

Pre-treatment circulating neutrophil count is an independent prognostic factor in oropharyngeal cancer
por: Li, Liang, et al.
Publicado: (2020)

Prognostic significance of pre-treatment serum Cyfra21-1 as a tumor marker in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy
por: Li, Liang, et al.
Publicado: (2020)

Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020)

The prognostic role of PSMD14 in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2022)

Regulation of Drp1 and enhancement of mitochondrial fission by the deubiquitinating enzyme PSMD14 facilitates the proliferation of bladder cancer cells
por: Song, Wei, et al.
Publicado: (2023)

The prognostic value of USP14 and PSMD14 expression in non-small cell lung cancer
por: Lei, Jian, et al.
Publicado: (2021)

PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation
por: Li, Xiao, et al.
Publicado: (2023)

PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism
por: Tan, Yanjie, et al.
Publicado: (2019)

An Arsenite Relay between PSMD14 and AIRAP Enables Revival of Proteasomal DUB Activity
por: Sukenik, Sigalit, et al.
Publicado: (2021)

Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma
por: Gong, Yubao, et al.
Publicado: (2021)

Identification of novel hub genes associated with lymph node metastasis of head and neck squamous cell carcinoma by completive bioinformatics analysis
por: Lu, Honglue, et al.
Publicado: (2021)

[Retracted] microRNA‑7 regulates cell growth, migration and invasion via direct targeting of PAK1 in thyroid cancer
por: Yue, Kai, et al.
Publicado: (2023)

The Proteasomal Deubiquitinating Enzyme PSMD14 Regulates Macroautophagy by Controlling Golgi-to-ER Retrograde Transport
por: Bustamante, Hianara A, et al.
Publicado: (2020)

Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2
por: Sun, Tianshui, et al.
Publicado: (2021)

PSMD7 downregulation suppresses lung cancer progression by regulating the p53 pathway
por: Xu, Xinchun, et al.
Publicado: (2021)

Deubiquitinase YOD1 suppresses tumor progression by stabilizing E3 ligase TRIM33 in head and neck squamous cell carcinoma
por: Wu, Yue, et al.
Publicado: (2023)

Prognostic role of pre-treatment serum ALB in Patients with oropharyngeal cancer: A retrospective cohort study
por: Zhu, Jiajia, et al.
Publicado: (2022)

Prognostic Significance of PSMD1 Expression in Patients with Gastric Cancer
por: Xiong, Wenjun, et al.
Publicado: (2019)

26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy
por: Rubio, Andres J., et al.
Publicado: (2021)

PSMD14 Targeting Triggers Paraptosis in Breast Cancer Cells by Inducing Proteasome Inhibition and Ca(2+) Imbalance
por: Lee, Hong-Jae, et al.
Publicado: (2022)

The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway
por: Seo, Dongyeob, et al.
Publicado: (2019)

PSMD12 promotes glioma progression by upregulating the expression of Nrf2
por: Wang, Zhongyong, et al.
Publicado: (2021)

PSMD9 expression predicts radiotherapy response in breast cancer
por: Langlands, Fiona E, et al.
Publicado: (2014)

Upregulation of PSMD4 gene by hypoxia in prostate cancer cells
por: AYDOĞAN TÜRKOĞLU, Sümeyye, et al.
Publicado: (2020)

Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma
por: Zhao, Huihui, et al.
Publicado: (2022)

Haploinsufficiency of PSMD12 Causes Proteasome Dysfunction and Subclinical Autoinflammation
por: Yan, Kai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_grt3rg7r1hgk4g0fnp1nt0kd51